SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Half Year Trading Update

16 Oct 2024 07:00

RNS Number : 3121I
Oxford Instruments PLC
16 October 2024
Β 

Β 

Oxford Instruments plc

Half-year trading update - 16 October 2024

Β 

Β 

Robust demand and order intake growthFull year trading in line with constant currency expectations

Β 

Oxford Instruments plc, a global provider of high technology products and services to many of the world's leading companies and scientific research communities, is today issuing a trading update for the half year ended 30 September 2024.

Β 

At constant currency, we expect to deliver circa 10% revenue growth for the first half, supported by order intake circa 3% ahead of the prior year. Adjusted operating profit will be slightly above last year. Group margin will be lower than last year, as expected, reflecting the mix effect of stronger revenue growth from Advanced Technologies.

Β 

On a reported basis, the currency headwind will result in adjusted operating profit and margin below the comparable period last year.

Β 

Imaging & Analysis

We have continued to see good growth in the first half of this financial year, with strong demand across our materials analysis and semiconductor markets. This more than offset softer demand from our healthcare & life science market. The division recorded a positive book-to-bill in the half year.

Β 

Advanced Technologies

Our compound semiconductor business continues to perform well, with strong revenue growth in the first half. In the quantum market, we have begun deliveries of an ongoing series of orders to a key customer, supporting good progress towards a return to profitability. The division continues to have good order book visibility.

Β 

Outlook

We expect to deliver our normal stronger second half trading performance. This will be supported by the execution of some larger orders in Advanced Technologies, as well as progress in our operational transformation and business restructuring projects, delivering efficiency and cost improvements in the second half of the year. We expect performance for the full year to be in line with expectations on a constant currency basis.

Β 

Based on prevailing exchange rates, the appreciation of sterling is expected to increase the currency headwind on operating profit for the full year by circa Β£1.5-2.0m from previous guidance.2

Β 

Oxford Instruments' results for the half year ending 30 September 2024 will be released on 12 November 2024.

Β 

Β 

Notes:

Β 

1. Adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, restructuring costs and the mark-to-market revaluation of financial derivatives.

2. Guidance in our 2024 preliminary full-year results announcement in June pointed to a headwind of Β£8.4m to revenue and Β£6.2m to profit for the full year.

Β 

Β 

Enquiries:

Β 

Oxford Instruments plc

Richard Tyson, Chief Executive Officer

Gavin Hill, Chief Financial Officer

Stephen Lamacraft, Head of Investor Relations

Β 

Tel: 01865 393200

investors@oxinst.com

Β 

MHP Group

Katie Hunt/Tim Rowntree/Eleni Menikou/Veronica Farah

Β 

Tel: 07710 117517

oxfordinstruments@mhpgroup.com

Β 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Β 

Notes to Editors Β 

Β 

About Oxford Instruments plc

Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science.

Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world. The vigorous search for new ways to make our world greener, healthier and more productive is driving unprecedented levels of R&D investment in new materials and techniques to support productivity and decarbonisation worldwide, creating a significant opportunity for Oxford Instruments to grow.

Oxford Instruments holds a unique position to anticipate global drivers and connect academic researchers with commercial applications engineers, acting as a catalyst that powers real world progress.

Founded in 1959 as the first technology business to be spun out fromβ€―Oxfordβ€―University, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG).

For more information, visit www.oxinst.comβ€―

Β 

β€―Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTQKPBQABDDPKD
Date   Source Headline
25th Jul 20257:00 amPRNDirector/PDMR Shareholding
25th Jul 20257:00 amPRNTransaction in Own Shares
24th Jul 20257:00 amPRNTransaction in Own Shares
23rd Jul 20257:00 amPRNTransaction in Own Shares
22nd Jul 20257:00 amPRNTransaction in Own Shares
21st Jul 20257:00 amPRNTransaction in Own Shares
18th Jul 20257:00 amPRNTransaction in Own Shares
17th Jul 20257:00 amPRNTransaction in Own Shares
16th Jul 20257:00 amPRNTransaction in Own Shares
15th Jul 20257:00 amPRNTransaction in Own Shares
14th Jul 20257:00 amPRNTransaction in Own Shares
11th Jul 20251:35 pmPRNDirector/PDMR Shareholding
11th Jul 20257:00 amPRNTransaction in Own Shares
10th Jul 20257:00 amPRNTransaction in Own Shares
9th Jul 20257:00 amPRNTransaction in Own Shares
8th Jul 20257:00 amPRNTransaction in Own Shares
7th Jul 202510:30 amPRNHolding(s) in Company
7th Jul 20257:00 amPRNTransaction in Own Shares
4th Jul 20257:00 amPRNTransaction in Own Shares
3rd Jul 20257:00 amPRNTransaction in Own Shares
2nd Jul 20254:07 pmPRNDirector/PDMR Shareholding - purchase of shares
2nd Jul 20257:00 amPRNTransaction in Own Shares
1st Jul 202512:28 pmPRNBlocklisting - Interim Review
1st Jul 202512:28 pmPRNTotal Voting Rights
1st Jul 20257:00 amPRNTransaction in Own Shares
30th Jun 20257:00 amPRNTransaction in Own Shares
27th Jun 20257:00 amPRNTransaction in Own Shares
26th Jun 20252:02 pmPRNBlock Listing Application
26th Jun 20257:00 amPRNTransaction in Own Shares
25th Jun 202512:14 pmPRNPublication of Annual Report 2025 and Notice of Annual General Meeting 2025
25th Jun 20257:00 amPRNCommencement of Share Buyback
24th Jun 20259:30 amPRNHolding(s) in Company
20th Jun 20257:00 amPRNDirector/PDMR Shareholding
18th Jun 20254:30 pmPRNHolding(s) in Company
13th Jun 20257:00 amRNSPreliminary Results
12th Jun 20252:43 pmRNSAnnouncement of Preliminary Results
11th Jun 20252:38 pmPRNDirector/PDMR Shareholding
10th Jun 20254:12 pmPRNHolding(s) in Company
10th Jun 20257:00 amRNSDelay to announcement of preliminary results
10th Jun 20257:00 amRNSSale of Oxford Instruments’ quantum business
2nd Jun 202512:33 pmPRNTotal Voting Rights
13th May 20253:45 pmPRNDirector/PDMR Shareholding
22nd Apr 20253:40 pmPRNHolding(s) in Company
17th Apr 20251:40 pmPRNHolding(s) in Company
16th Apr 20257:00 amRNSTrading Update
15th Apr 20251:30 pmPRNHolding(s) in Company
14th Apr 20253:33 pmPRNDirector/PDMR Shareholding
10th Apr 20257:00 amRNSHolding(s) in Company
1st Apr 20257:00 amRNSTotal Voting Rights
25th Mar 202512:35 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.